A version of this sentence is found on countless UK life science company websites:
“We are a leading provider of integrated, innovative solutions leveraging cutting-edge science to deliver best-in-class outcomes for our clients.”
It means nothing. It could have been written by anyone, about anything. And yet it sits on the homepage of companies doing genuinely extraordinary work — companies whose science could change lives, whose technology is years ahead of the competition, whose expertise is world-class by any measure.
This is the life science marketing problem. And it’s more damaging than most people in the sector acknowledge.
The gap between science and communication
Life science companies are, understandably, science-led. The founders are scientists. The leadership teams came up through research, clinical development, or regulatory affairs. The culture values rigour, precision, and evidence.
Marketing — with its emphasis on storytelling, emotion, and persuasion — can feel uncomfortably imprecise in that environment. The result is a sector that often defaults to either impenetrable technical language that only specialists understand or vague corporate-speak that nobody believes.
Neither works.
The irony is that the science itself is often the most compelling story imaginable. A CRO that has spent twenty years developing a proprietary toxicology screening method that reduces false positives by 40% has an extraordinary story to tell. A biotech with a novel small molecule platform that could halve the time to clinical trial has something genuinely exciting to say.
But if that story is buried in a PDF, described in jargon, or simply never told — it might as well not exist.
The commercial cost of poor communication
This isn’t just an aesthetic problem. Poor marketing has real commercial consequences for life science companies.
Potential partners who can’t quickly understand what you do will move on to a competitor who explains themselves more clearly. Investors doing due diligence on your website will draw conclusions about your professionalism based on what they find. BD leads who ask an AI tool for specialist CRO recommendations will be directed to companies whose content is structured, authoritative, and clear.
The Inpart Partnering 2030 report — which surveyed 180 biotech companies and 107 research institutes — found that transparency and communication were ranked as the most important partnering values for the second consecutive year. Above money. Above scientific track record. Above resources.
The companies your potential partners most want to work with are the ones that communicate clearly, honestly, and specifically. Not the ones who hide behind corporate language.
What good life science marketing actually looks like
Good life science marketing doesn’t dumb things down. It doesn’t sensationalise. It doesn’t pretend that science is simpler than it is.
What it does is translate. It takes genuinely complex, genuinely important science and finds the clearest possible way to communicate its value to the people who need to understand it — whether that’s a pharma BD director, a VC investor, a potential partner, or a regulatory body.
It asks four questions that every piece of communication should be able to answer: What do you do? Who do you do it for? Why does it matter? Why should I trust you?
And it answers them plainly, specifically, and consistently — across the website, the LinkedIn page, the conference stand, the pitch deck, and every other touchpoint where a potential partner might encounter the brand.
That’s not a compromise of scientific rigour. It’s an application of it.
The sector deserves better.
The UK life science sector is extraordinary. The North West corridor alone is worth £7.7bn annually and is home to some of Europe’s most innovative companies. The science being done at Alderley Park, in Manchester, in Macclesfield, and across the region is genuinely world-class.
It deserves marketing that matches.
Zool is a specialist life science marketing agency based at No.1 Alderley Park. We help life science businesses across the UK achieve measurable growth by translating complex science into clear messaging, building credible brands, and executing campaigns that deliver real results. If you’re ready to stand out in the market and achieve your business goals, contact us today on 01625 238 770 or [email protected].
The Life Science Marketing Problem Nobody Talks About
Life Science / Apr 6, 2026
A version of this sentence is found on countless UK life science company websites:
“We are a leading provider of integrated, innovative solutions leveraging cutting-edge science to deliver best-in-class outcomes for our clients.”
It means nothing. It could have been written by anyone, about anything. And yet it sits on the homepage of companies doing genuinely extraordinary work — companies whose science could change lives, whose technology is years ahead of the competition, whose expertise is world-class by any measure.
This is the life science marketing problem. And it’s more damaging than most people in the sector acknowledge.
The gap between science and communication
Life science companies are, understandably, science-led. The founders are scientists. The leadership teams came up through research, clinical development, or regulatory affairs. The culture values rigour, precision, and evidence.
Marketing — with its emphasis on storytelling, emotion, and persuasion — can feel uncomfortably imprecise in that environment. The result is a sector that often defaults to either impenetrable technical language that only specialists understand or vague corporate-speak that nobody believes.
Neither works.
The irony is that the science itself is often the most compelling story imaginable. A CRO that has spent twenty years developing a proprietary toxicology screening method that reduces false positives by 40% has an extraordinary story to tell. A biotech with a novel small molecule platform that could halve the time to clinical trial has something genuinely exciting to say.
But if that story is buried in a PDF, described in jargon, or simply never told — it might as well not exist.
The commercial cost of poor communication
This isn’t just an aesthetic problem. Poor marketing has real commercial consequences for life science companies.
Potential partners who can’t quickly understand what you do will move on to a competitor who explains themselves more clearly. Investors doing due diligence on your website will draw conclusions about your professionalism based on what they find. BD leads who ask an AI tool for specialist CRO recommendations will be directed to companies whose content is structured, authoritative, and clear.
The Inpart Partnering 2030 report — which surveyed 180 biotech companies and 107 research institutes — found that transparency and communication were ranked as the most important partnering values for the second consecutive year. Above money. Above scientific track record. Above resources.
The companies your potential partners most want to work with are the ones that communicate clearly, honestly, and specifically. Not the ones who hide behind corporate language.
What good life science marketing actually looks like
Good life science marketing doesn’t dumb things down. It doesn’t sensationalise. It doesn’t pretend that science is simpler than it is.
What it does is translate. It takes genuinely complex, genuinely important science and finds the clearest possible way to communicate its value to the people who need to understand it — whether that’s a pharma BD director, a VC investor, a potential partner, or a regulatory body.
It asks four questions that every piece of communication should be able to answer: What do you do? Who do you do it for? Why does it matter? Why should I trust you?
And it answers them plainly, specifically, and consistently — across the website, the LinkedIn page, the conference stand, the pitch deck, and every other touchpoint where a potential partner might encounter the brand.
That’s not a compromise of scientific rigour. It’s an application of it.
The sector deserves better.
The UK life science sector is extraordinary. The North West corridor alone is worth £7.7bn annually and is home to some of Europe’s most innovative companies. The science being done at Alderley Park, in Manchester, in Macclesfield, and across the region is genuinely world-class.
It deserves marketing that matches.
Zool is a specialist life science marketing agency based at No.1 Alderley Park. We help life science businesses across the UK achieve measurable growth by translating complex science into clear messaging, building credible brands, and executing campaigns that deliver real results. If you’re ready to stand out in the market and achieve your business goals, contact us today on 01625 238 770 or [email protected].
